Teva Pharmaceutical Industries Ltd.
(NYSE : TEVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
1.22%158.252.9%$705.46m
ZTSZoetis, Inc. Class A
1.35%125.351.9%$244.96m
MYLMylan N.V.
5.22%18.533.2%$193.76m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
3.73%6.392.0%$144.12m
TXMDTherapeuticsMD, Inc.
-3.70%2.8624.9%$10.87m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.03%35.252.0%$8.03m
TAROTaro Pharmaceutical Industries Ltd.
1.24%81.526.4%$3.46m
KINKindred Biosciences, Inc.
4.45%7.280.3%$1.76m
ABEOAbeona Therapeutics, Inc.
1.38%2.207.6%$1.52m
LFVNLifeVantage Corporation
-6.41%11.683.3%$1.06m
JAGXJaguar Animal Health, Inc.
-8.26%1.119.8%$0.59m
CPHIChina Pharma Holdings, Inc.
-1.12%0.260.1%$0.05m

Company Profile

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.